rs3774729

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001377405.1(ATXN7):​c.2584G>A​(p.Val862Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.329 in 1,613,796 control chromosomes in the GnomAD database, including 91,264 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.40 ( 13143 hom., cov: 31)
Exomes 𝑓: 0.32 ( 78121 hom. )

Consequence

ATXN7
NM_001377405.1 missense

Scores

18

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.264

Publications

43 publications found
Variant links:
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
ATXN7 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • spinocerebellar ataxia type 7
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.7316197E-5).
BP6
Variant 3-63996406-G-A is Benign according to our data. Variant chr3-63996406-G-A is described in ClinVar as [Benign]. Clinvar id is 128518.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN7NM_001377405.1 linkc.2584G>A p.Val862Met missense_variant Exon 12 of 13 ENST00000674280.1 NP_001364334.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN7ENST00000674280.1 linkc.2584G>A p.Val862Met missense_variant Exon 12 of 13 NM_001377405.1 ENSP00000501377.1 O15265-1

Frequencies

GnomAD3 genomes
AF:
0.398
AC:
60465
AN:
151806
Hom.:
13114
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.578
Gnomad AMI
AF:
0.359
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.412
Gnomad EAS
AF:
0.481
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.324
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.317
Gnomad OTH
AF:
0.404
GnomAD2 exomes
AF:
0.344
AC:
85844
AN:
249242
AF XY:
0.339
show subpopulations
Gnomad AFR exome
AF:
0.584
Gnomad AMR exome
AF:
0.296
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.495
Gnomad FIN exome
AF:
0.315
Gnomad NFE exome
AF:
0.315
Gnomad OTH exome
AF:
0.342
GnomAD4 exome
AF:
0.322
AC:
470748
AN:
1461872
Hom.:
78121
Cov.:
53
AF XY:
0.321
AC XY:
233722
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.587
AC:
19664
AN:
33480
American (AMR)
AF:
0.301
AC:
13482
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
10427
AN:
26136
East Asian (EAS)
AF:
0.478
AC:
18971
AN:
39700
South Asian (SAS)
AF:
0.298
AC:
25715
AN:
86258
European-Finnish (FIN)
AF:
0.322
AC:
17225
AN:
53418
Middle Eastern (MID)
AF:
0.337
AC:
1945
AN:
5768
European-Non Finnish (NFE)
AF:
0.308
AC:
342115
AN:
1111992
Other (OTH)
AF:
0.351
AC:
21204
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
21649
43299
64948
86598
108247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11360
22720
34080
45440
56800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.399
AC:
60542
AN:
151924
Hom.:
13143
Cov.:
31
AF XY:
0.396
AC XY:
29409
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.578
AC:
23944
AN:
41404
American (AMR)
AF:
0.332
AC:
5065
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.412
AC:
1429
AN:
3470
East Asian (EAS)
AF:
0.481
AC:
2467
AN:
5126
South Asian (SAS)
AF:
0.289
AC:
1396
AN:
4834
European-Finnish (FIN)
AF:
0.324
AC:
3425
AN:
10564
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.317
AC:
21523
AN:
67948
Other (OTH)
AF:
0.404
AC:
853
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1774
3549
5323
7098
8872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
560
1120
1680
2240
2800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.343
Hom.:
36826
Bravo
AF:
0.409
TwinsUK
AF:
0.294
AC:
1089
ALSPAC
AF:
0.309
AC:
1190
ESP6500AA
AF:
0.558
AC:
2374
ESP6500EA
AF:
0.307
AC:
2612
ExAC
AF:
0.347
AC:
42058
Asia WGS
AF:
0.422
AC:
1468
AN:
3478
EpiCase
AF:
0.311
EpiControl
AF:
0.312

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.5
DANN
Benign
0.17
DEOGEN2
Benign
0.086
.;T;.;T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.51
T;T;T;.;.;T
MetaRNN
Benign
0.000037
T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.79
.;N;N;N;N;.
PhyloP100
-0.26
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.45
.;N;N;N;.;N
REVEL
Benign
0.074
Sift
Benign
1.0
.;T;T;T;.;T
Sift4G
Benign
0.81
.;T;T;T;.;T
Polyphen
0.0050, 0.028
.;B;B;B;B;.
Vest4
0.032, 0.035, 0.071
ClinPred
0.0012
T
GERP RS
-1.6
Varity_R
0.017
gMVP
0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774729; hg19: chr3-63982082; COSMIC: COSV55751053; COSMIC: COSV55751053; API